CTSS and neoplasm: Combining PTX with cathepsin deletion [by JPM-OEt (JPM), a pan-cathepsin inhibitor] significantly improved therapeutic efficacy of PTX, inhibited tumor growth and metastatic burden, and improved late-stage survival (95).